Novo Nordisk A/S (NYSE:NVO) Rating Increased to Hold at Zacks Research
Zacks Research upgraded shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a strong sell rating to a hold rating in a research report released on Monday morning,Zacks.com reports. Several other analysts have also recently weighed in on the company. Morg…